Views & Analysis Transforming pharma R&D with a scientist-centric approach to... As biopharmaceutical products have become increasingly complex, both in design and in regulatory requirements, we need a new way of working.
Market Access A roadmap for adopting New Science The pandemic’s disruption galvanised the biopharma industry into unprecedented action, demonstrating what’s possible when the global scientific community collaborates in exceptional ways an
Videos Health Innovators: Graeme Duncan, Advanz Pharma In this episode of our Health Innovators series, Paul Tunnah interviews Graeme Duncan, CEO of specialty p
Views & Analysis What HCPs think about blood clots linked to COVID-19 vaccine... In the latest edition of What HCPs Think, CREATION.co's Laura Marsh looks at what healthcare professionals
Views & Analysis Are microtaggants the key to making medicines smarter? Pharmaceutical companies are accountable for ensuring that their medicine is safe when it comes into the hands of patients.
Digital Now what? The future of clinical trials after the pandemic Sheila Rocchio highlights four key areas life sciences must improve on as an industry to drive real change in how clinical trials are conducted.
News Aspen, Bambusa close IPOs as Corxel takes SPAC route Aspen Neuroscience and Bambusa Therapeutics get their Nasdaq IPOs over the line, while Corxel eyes a debut via a blank-cheque company merger.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.